Smoking cessation in heart failure: It is never too late

Journal of the American College of Cardiology

Volumn 37, Issue 6, 2001, Pages 1683-1684

  Spieker, Lukas E ^a   Noll, Georg ^a   Ruschitzka, Frank T ^a   Lüscher, Thomas F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICOTINE;

CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; DRUG COST; EDITORIAL; HEALTH BEHAVIOR; HEALTH CARE COST; HEART FAILURE; HUMAN; MORBIDITY; MORTALITY; PATIENT COUNSELING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION;

COST-BENEFIT ANALYSIS; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035042274     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01188-3     Document Type: Editorial

References (17)

1. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction
2. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (HERIT-HF[MERIT-HF])
4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators
5. Physicians counseling smokers: A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions
6. A population-based survey of physician smoking cessation counseling practices
7. Quality of care for patients hospitalized with heart failure at academic medical centers
8. A randomized controlled trial of smoking cessation counseling after myocardial infarction
9. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure
10. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization
11. The cost-effectiveness of the nicotine transdermal patch for smoking cessation
12. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies: ACE inhibitors in the management of congestive heart failure: Comparative economic data
13. Cost effectiveness of carvedilol for heart failure
14. The new role of beta blockers in congestive heart failure
15. Short-term economic and health benefits of smoking cessation: Myocardial infarction and stroke
16. Association of the California tobacco control program with declines in cigarette consumption and mortality from heart disease